RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages

P Dieter, E Fitzke - Biochemical and biophysical research communications, 1991 - Elsevier
P Dieter, E Fitzke
Biochemical and biophysical research communications, 1991Elsevier
Two new potent protein kinase C inhibitors, RO 31-8220 and RO 31-7549, and
staurosporine were found to inhibit dose-dependently the phorbol ester-induced formation of
prostaglandin E 2 and superoxide in cultured liver macrophages. Prostaglandin E 2
formation from exogenously added arachidonate was not affected by these compounds. The
zymosan-induced formation of inositol phosphates was decreased by simultaneous addition
of phorbol ester and was enhanced by prior desensitization of protein kinase C indicating …
Summary
Two new potent protein kinase C inhibitors, RO 31-8220 and RO 31-7549, and staurosporine were found to inhibit dose-dependently the phorbol ester-induced formation of prostaglandin E2and superoxide in cultured liver macrophages. Prostaglandin E2formation from exogenously added arachidonate was not affected by these compounds. The zymosan-induced formation of inositol phosphates was decreased by simultaneous addition of phorbol ester and was enhanced by prior desensitization of protein kinase C indicating that protein kinase C negatively modulates phospholipase C activation in these cells. While staurosporine suppressed almost totally the zymosan-induced formation of inositol phosphates, RO 31-8220 and RO 31-7549 inhibited the protein kinase C-mediated effect on inositol phosphate formation, only. Phagocytosis of zymosan was not affected by RO 31-8220 and RO 31-7549 but was decreased by staurosporine. These results demonstrate that two new potent protein kinase C inhibitors, RO 31-8220 and RO 31-7549, are more selective in their actions as staurosporine and are useful tools to determine an involvement of protein kinase C in cellular systems.
Elsevier